<unk>  is an antineoplastic agent that is FDA approved for the treatment of chronic lymphoid leukemia,previously untreated. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include anemia, neutropenia,thrombocytopenia, musculoskeletal system disorder,cough,  fever.
Obinutuzumab
Volociximab
Idarucizumab
Blinatumomab
Bavituximab
Elotuzumab
Acalabrutinib
Epratuzumab